| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/09/1994 | WO1994012481A1 Novel isoxazolines as antiinflammatory agents |
| 06/09/1994 | WO1994012466A1 Fatty acid derivatives and pharmaceutical compositions containing them |
| 06/09/1994 | WO1994012461A1 Catechol diethers as selective pdeiv inhibitors |
| 06/09/1994 | WO1994012203A1 DRUGS CONTAINING reg PROTEIN AS ACTIVE INGREDIENT |
| 06/09/1994 | WO1994012181A1 Fibrinogen receptor antagonists |
| 06/09/1994 | WO1994012178A1 Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds |
| 06/09/1994 | WO1994012177A1 Antioxydant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds |
| 06/09/1994 | WO1994012169A1 Carboxy-peptidyl derivatives as antidegenerative active agents |
| 06/09/1994 | WO1994012165A2 Enzyme inhibitors |
| 06/09/1994 | WO1994012164A1 Combination of atovaquone with proguanil for the treatment of protozoal infections |
| 06/09/1994 | WO1994012162A1 Syndecan stimulation of cellular differentiation |
| 06/09/1994 | WO1994008949A3 Metal-oxime chelates for use as radiopharmaceutical agents |
| 06/09/1994 | WO1994006913A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/09/1994 | WO1994003177A3 Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them |
| 06/09/1994 | DE4341332A1 4-Alkyl- und 4-Alkenyl-Delta-3-Cephemsulfone 4-alkyl- and 4-alkenyl-3-Delta Cephemsulfone |
| 06/09/1994 | CA2592997A1 Pseudo-adenovirus vectors |
| 06/09/1994 | CA2400368A1 Catechol diethers as selective pde iv inhibitors |
| 06/09/1994 | CA2150695A1 Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds |
| 06/09/1994 | CA2150694A1 Antioxydant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds |
| 06/09/1994 | CA2150550A1 Fibrinogen receptor antagonists |
| 06/09/1994 | CA2150117A1 Interleukin-3 (il-3) mutant polypeptides |
| 06/09/1994 | CA2150116A1 Interleukin-3 (il-3) multiple mutation polypeptides |
| 06/09/1994 | CA2149882A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 06/09/1994 | CA2149785A1 Antagonists of human gamma interferon |
| 06/09/1994 | CA2149640A1 Carboxy-peptidyl derivatives as antidegenerative active agents |
| 06/09/1994 | CA2110116A1 Substituted benzoic acids |
| 06/09/1994 | CA2102592A1 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 06/08/1994 | EP0600832A1 Derivatives of diamino benzoic and diamino phthalic acid und their use as protein linase inhibitors |
| 06/08/1994 | EP0600831A1 Phtalazinon derivatives |
| 06/08/1994 | EP0600830A1 Substituted derivatives of diaminophthalimide as protein-tyrosine kinase inhibitors |
| 06/08/1994 | EP0600371A1 Guanidinyl alkyl-1,1- bis phosphonic acid derivatives, process for their preparation and use |
| 06/08/1994 | EP0600084A1 Indole derivatives |
| 06/08/1994 | EP0600079A1 ORAL 1$g(a)-HYDROXYPREVITAMIN D |
| 06/08/1994 | EP0600028A1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 06/08/1994 | EP0599943A1 Leukotriene receptor antagonist-antihistamine complex |
| 06/08/1994 | EP0517789B1 Inhibitor of proliferation of endothelial cells |
| 06/08/1994 | EP0462194B1 Fibroblast growth factor (fgf)-based stabilized compositions |
| 06/08/1994 | CN1087625A N-(hydr oxyethyl) butanediamide derivatives |
| 06/08/1994 | CN1087531A Oily preparation and method of production thereof |
| 06/07/1994 | US5319139 Naphthalene derivatives |
| 06/07/1994 | US5318991 Fatty acid treatment to reduce calcium excretion |
| 06/07/1994 | US5318988 2-aminomethyl-chromans |
| 06/07/1994 | US5318985 Potentiation of NMDA antagonists |
| 06/07/1994 | US5318980 Antihypertensive and antiatherosclerotic agents |
| 06/07/1994 | US5318970 Isoxazole compounds, pharmaceutically acceptable salts thereof and medical uses thereof |
| 06/07/1994 | US5318964 Hydroxamic derivatives and pharmaceutical compositions |
| 06/01/1994 | EP0599479A2 Lactobacillus used to enhance immunological functions |
| 06/01/1994 | EP0599444A1 Dual action inhibitors |
| 06/01/1994 | EP0599397A1 Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive collagen crosslinking during diabetes |
| 06/01/1994 | EP0598754A1 Indoles |
| 06/01/1994 | EP0598750A1 Indoles |
| 06/01/1994 | EP0484437A4 Renal-selective prodrugs for the treatment of hypertension |
| 06/01/1994 | EP0479912B1 Inhibition of the n-end rule pathway in living cells |
| 06/01/1994 | EP0328535B1 The administration of monoamine acridines in cholinergic neuronal deficit states |
| 06/01/1994 | DE4228458A1 Multicistronische Expressionseinheiten und deren Verwendung Multicistronic expression units and their use |
| 06/01/1994 | CN1087341A N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 06/01/1994 | CN1087339A Piperidine derivative, preparation of same and medical use of same |
| 06/01/1994 | CN1087337A Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives |
| 06/01/1994 | CN1087278A New use of lysozyme dimer and compositions containing the same |
| 06/01/1994 | CN1024791C Process for preparing pyrrolidine derivatives and their salts |
| 06/01/1994 | CN1024790C Urea derivatives and salts thereof and method for producing same |
| 05/31/1994 | US5317088 Binding |
| 05/31/1994 | US5317029 Treatment and prevention of diseases associated with bone metabolism |
| 05/31/1994 | US5317023 2-Phenyl-(imidazo(4,5-b)pyridyl-methyl-) derivatives; hypertensive agents; cognition activators |
| 05/31/1994 | US5317021 Analgesics, anticonvulsants |
| 05/31/1994 | US5317019 Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages |
| 05/31/1994 | US5317017 N-biphenyl-3-amido substituted benzolactams stimulate growth hormone release |
| 05/31/1994 | US5317010 Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment |
| 05/31/1994 | US5316925 T-cell receptor specific for antigen polypeptides and related polynucleotides |
| 05/31/1994 | US5316920 Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily |
| 05/31/1994 | CA2110110A1 Use of certain methanebisphosphonic acid derivatives in fracture healing |
| 05/31/1994 | CA1329937C 1-phenyl-3-naphthalenyloxypropanamines |
| 05/31/1994 | CA1329932C Acyl deoxyribonucleoside derivatives and uses thereof |
| 05/28/1994 | CA2109993A1 Substituted derivatives of diaminophthalimide |
| 05/28/1994 | CA2109992A1 Phthalazinone derivatives |
| 05/28/1994 | CA2109975A1 Diaminobenzoic acid derivatives |
| 05/26/1994 | WO1994011522A2 Vector for the expression of therapy-relevant genes |
| 05/26/1994 | WO1994011395A1 Peptide inhibitors of fibronectin and related collagen-binding proteins |
| 05/26/1994 | WO1994011377A2 Water soluble camptothecin derivatives |
| 05/26/1994 | WO1994011370A1 Substituted amino alkyl compounds |
| 05/26/1994 | WO1994011368A1 Quinuclidine derivative as substance p antagonist |
| 05/26/1994 | WO1994011342A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis |
| 05/26/1994 | WO1994011341A1 Substituted amidino compounds, their manufacture and methods of treatment |
| 05/26/1994 | WO1994011338A1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacentates or n, n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress |
| 05/26/1994 | WO1994011027A1 Peripheralization of hematopoietic stem cells |
| 05/26/1994 | WO1994011020A1 Eck receptor ligands |
| 05/26/1994 | WO1994011014A1 Compounds that inhibit t cell proliferation and methods using the same |
| 05/26/1994 | WO1994011012A1 Substituted dipeptide analogs promote release of growth hormone |
| 05/26/1994 | WO1994011011A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |
| 05/26/1994 | WO1994011010A2 Compositions of oak bark extract, related synthetic compositions, and method of using same |
| 05/26/1994 | WO1994011008A1 Fluidized intestinal submucosa and its use as an injectable tissue graft |
| 05/26/1994 | WO1994011007A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | WO1994011006A1 Compositions for the regulation of cytokine activity |
| 05/26/1994 | WO1994010990A1 Inhibition of tnf production |
| 05/26/1994 | WO1994010989A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
| 05/26/1994 | WO1994006909A3 A method of preventing tumor metastasis |
| 05/26/1994 | WO1994004120A3 Methods of treating sexual dysfunction in animals with and h agonist |
| 05/26/1994 | WO1994002510A3 Analogs of pth |
| 05/26/1994 | DE4239150A1 O-acyl-4-phenyl-cyclohexanol derivs. - are inhibitors of 2,3-epoxy:squalene-lanosterol cyclase and useful as anti-hypercholesterolaemic for treating atherosclerosis |
| 05/26/1994 | CA2149431A1 Use of n-arylmethylene ethylenediamine-triacetates, n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates against oxidizing stress |